- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.37 Å
- Oligo State
- homo-octamer
- Ligands
- 16 x MN: MANGANESE (II) ION(Non-covalent)
- 40 x SO4: SULFATE ION(Non-functional Binders)
SO4.3: 4 residues within 4Å:- Chain A: G.72, S.73, R.76, K.114
Ligand excluded by PLIPSO4.4: 1 residues within 4Å:- Chain A: R.169
Ligand excluded by PLIPSO4.5: 6 residues within 4Å:- Chain A: I.50, E.51, T.52, N.53, K.54, S.195
Ligand excluded by PLIPSO4.8: 7 residues within 4Å:- Chain A: N.53, K.54, A.57, R.125, S.195, E.196
- Ligands: 09Y.7
Ligand excluded by PLIPSO4.9: 6 residues within 4Å:- Chain A: E.78, R.83, V.91
- Chain D: T.174, R.175, T.178
Ligand excluded by PLIPSO4.12: 4 residues within 4Å:- Chain B: G.72, S.73, R.76, K.114
Ligand excluded by PLIPSO4.13: 1 residues within 4Å:- Chain B: R.169
Ligand excluded by PLIPSO4.14: 6 residues within 4Å:- Chain B: I.50, E.51, T.52, N.53, K.54, S.195
Ligand excluded by PLIPSO4.17: 7 residues within 4Å:- Chain B: N.53, K.54, A.57, R.125, S.195, E.196
- Ligands: 09Y.16
Ligand excluded by PLIPSO4.18: 6 residues within 4Å:- Chain B: E.78, R.83, V.91
- Chain C: T.174, R.175, T.178
Ligand excluded by PLIPSO4.21: 4 residues within 4Å:- Chain C: G.72, S.73, R.76, K.114
Ligand excluded by PLIPSO4.22: 1 residues within 4Å:- Chain C: R.169
Ligand excluded by PLIPSO4.23: 6 residues within 4Å:- Chain C: I.50, E.51, T.52, N.53, K.54, S.195
Ligand excluded by PLIPSO4.26: 7 residues within 4Å:- Chain C: N.53, K.54, A.57, R.125, S.195, E.196
- Ligands: 09Y.25
Ligand excluded by PLIPSO4.27: 6 residues within 4Å:- Chain A: T.174, R.175, T.178
- Chain C: E.78, R.83, V.91
Ligand excluded by PLIPSO4.30: 4 residues within 4Å:- Chain D: G.72, S.73, R.76, K.114
Ligand excluded by PLIPSO4.31: 1 residues within 4Å:- Chain D: R.169
Ligand excluded by PLIPSO4.32: 6 residues within 4Å:- Chain D: I.50, E.51, T.52, N.53, K.54, S.195
Ligand excluded by PLIPSO4.35: 7 residues within 4Å:- Chain D: N.53, K.54, A.57, R.125, S.195, E.196
- Ligands: 09Y.34
Ligand excluded by PLIPSO4.36: 6 residues within 4Å:- Chain B: T.174, R.175, T.178
- Chain D: E.78, R.83, V.91
Ligand excluded by PLIPSO4.39: 4 residues within 4Å:- Chain E: G.72, S.73, R.76, K.114
Ligand excluded by PLIPSO4.40: 1 residues within 4Å:- Chain E: R.169
Ligand excluded by PLIPSO4.41: 6 residues within 4Å:- Chain E: I.50, E.51, T.52, N.53, K.54, S.195
Ligand excluded by PLIPSO4.44: 7 residues within 4Å:- Chain E: N.53, K.54, A.57, R.125, S.195, E.196
- Ligands: 09Y.43
Ligand excluded by PLIPSO4.45: 6 residues within 4Å:- Chain E: E.78, R.83, V.91
- Chain H: T.174, R.175, T.178
Ligand excluded by PLIPSO4.48: 4 residues within 4Å:- Chain F: G.72, S.73, R.76, K.114
Ligand excluded by PLIPSO4.49: 1 residues within 4Å:- Chain F: R.169
Ligand excluded by PLIPSO4.50: 6 residues within 4Å:- Chain F: I.50, E.51, T.52, N.53, K.54, S.195
Ligand excluded by PLIPSO4.53: 7 residues within 4Å:- Chain F: N.53, K.54, A.57, R.125, S.195, E.196
- Ligands: 09Y.52
Ligand excluded by PLIPSO4.54: 6 residues within 4Å:- Chain F: E.78, R.83, V.91
- Chain G: T.174, R.175, T.178
Ligand excluded by PLIPSO4.57: 4 residues within 4Å:- Chain G: G.72, S.73, R.76, K.114
Ligand excluded by PLIPSO4.58: 1 residues within 4Å:- Chain G: R.169
Ligand excluded by PLIPSO4.59: 6 residues within 4Å:- Chain G: I.50, E.51, T.52, N.53, K.54, S.195
Ligand excluded by PLIPSO4.62: 7 residues within 4Å:- Chain G: N.53, K.54, A.57, R.125, S.195, E.196
- Ligands: 09Y.61
Ligand excluded by PLIPSO4.63: 6 residues within 4Å:- Chain E: T.174, R.175, T.178
- Chain G: E.78, R.83, V.91
Ligand excluded by PLIPSO4.66: 4 residues within 4Å:- Chain H: G.72, S.73, R.76, K.114
Ligand excluded by PLIPSO4.67: 1 residues within 4Å:- Chain H: R.169
Ligand excluded by PLIPSO4.68: 6 residues within 4Å:- Chain H: I.50, E.51, T.52, N.53, K.54, S.195
Ligand excluded by PLIPSO4.71: 7 residues within 4Å:- Chain H: N.53, K.54, A.57, R.125, S.195, E.196
- Ligands: 09Y.70
Ligand excluded by PLIPSO4.72: 6 residues within 4Å:- Chain F: T.174, R.175, T.178
- Chain H: E.78, R.83, V.91
Ligand excluded by PLIP- 8 x QQ4: Hexa Vinylpyrrolidone K15(Non-covalent)
QQ4.6: 4 residues within 4Å:- Chain A: M.32, F.66, I.79, E.81
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:F.66, A:F.66, A:I.79
QQ4.15: 4 residues within 4Å:- Chain B: M.32, F.66, I.79, E.81
3 PLIP interactions:3 interactions with chain B- Hydrophobic interactions: B:F.66, B:F.66, B:I.79
QQ4.24: 4 residues within 4Å:- Chain C: M.32, F.66, I.79, E.81
3 PLIP interactions:3 interactions with chain C- Hydrophobic interactions: C:F.66, C:F.66, C:I.79
QQ4.33: 4 residues within 4Å:- Chain D: M.32, F.66, I.79, E.81
3 PLIP interactions:3 interactions with chain D- Hydrophobic interactions: D:F.66, D:F.66, D:I.79
QQ4.42: 4 residues within 4Å:- Chain E: M.32, F.66, I.79, E.81
3 PLIP interactions:3 interactions with chain E- Hydrophobic interactions: E:F.66, E:F.66, E:I.79
QQ4.51: 4 residues within 4Å:- Chain F: M.32, F.66, I.79, E.81
3 PLIP interactions:3 interactions with chain F- Hydrophobic interactions: F:F.66, F:F.66, F:I.79
QQ4.60: 4 residues within 4Å:- Chain G: M.32, F.66, I.79, E.81
3 PLIP interactions:3 interactions with chain G- Hydrophobic interactions: G:F.66, G:F.66, G:I.79
QQ4.69: 4 residues within 4Å:- Chain H: M.32, F.66, I.79, E.81
3 PLIP interactions:3 interactions with chain H- Hydrophobic interactions: H:F.66, H:F.66, H:I.79
- 8 x 09Y: 5-hydroxy-N-[2-(2-methoxypyridin-4-yl)ethyl]-2-(2-methylphenyl)-6-oxo-1,6-dihydropyrimidine-4-carboxamide(Non-covalent)
09Y.7: 14 residues within 4Å:- Chain A: A.40, Y.44, K.54, I.58, H.61, E.81, L.107, D.109, E.120, I.121, Y.131
- Ligands: MN.1, MN.2, SO4.8
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:A.40, A:Y.44, A:Y.44, A:K.54
- Water bridges: A:V.123
09Y.16: 14 residues within 4Å:- Chain B: A.40, Y.44, K.54, I.58, H.61, E.81, L.107, D.109, E.120, I.121, Y.131
- Ligands: MN.10, MN.11, SO4.17
5 PLIP interactions:5 interactions with chain B- Hydrophobic interactions: B:A.40, B:Y.44, B:Y.44, B:K.54
- Water bridges: B:V.123
09Y.25: 14 residues within 4Å:- Chain C: A.40, Y.44, K.54, I.58, H.61, E.81, L.107, D.109, E.120, I.121, Y.131
- Ligands: MN.19, MN.20, SO4.26
5 PLIP interactions:5 interactions with chain C- Hydrophobic interactions: C:A.40, C:Y.44, C:Y.44, C:K.54
- Water bridges: C:V.123
09Y.34: 14 residues within 4Å:- Chain D: A.40, Y.44, K.54, I.58, H.61, E.81, L.107, D.109, E.120, I.121, Y.131
- Ligands: MN.28, MN.29, SO4.35
8 PLIP interactions:8 interactions with chain D- Hydrophobic interactions: D:A.40, D:Y.44, D:Y.44, D:K.54
- Hydrogen bonds: D:E.120, D:I.121
- Water bridges: D:D.109, D:V.123
09Y.43: 14 residues within 4Å:- Chain E: A.40, Y.44, K.54, I.58, H.61, E.81, L.107, D.109, E.120, I.121, Y.131
- Ligands: MN.37, MN.38, SO4.44
6 PLIP interactions:6 interactions with chain E- Hydrophobic interactions: E:A.40, E:Y.44, E:Y.44, E:K.54
- Hydrogen bonds: E:Y.131
- Water bridges: E:V.123
09Y.52: 14 residues within 4Å:- Chain F: A.40, Y.44, K.54, I.58, H.61, E.81, L.107, D.109, E.120, I.121, Y.131
- Ligands: MN.46, MN.47, SO4.53
6 PLIP interactions:6 interactions with chain F- Hydrophobic interactions: F:A.40, F:Y.44, F:Y.44, F:K.54
- Hydrogen bonds: F:Y.131
- Water bridges: F:V.123
09Y.61: 14 residues within 4Å:- Chain G: A.40, Y.44, K.54, I.58, H.61, E.81, L.107, D.109, E.120, I.121, Y.131
- Ligands: MN.55, MN.56, SO4.62
6 PLIP interactions:6 interactions with chain G- Hydrophobic interactions: G:A.40, G:Y.44, G:Y.44, G:K.54
- Hydrogen bonds: G:Y.131
- Water bridges: G:V.123
09Y.70: 14 residues within 4Å:- Chain H: A.40, Y.44, K.54, I.58, H.61, E.81, L.107, D.109, E.120, I.121, Y.131
- Ligands: MN.64, MN.65, SO4.71
8 PLIP interactions:8 interactions with chain H- Hydrophobic interactions: H:A.40, H:Y.44, H:Y.44, H:K.54
- Hydrogen bonds: H:E.81, H:I.121, H:Y.131
- Water bridges: H:V.123
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Slavish, P.J. et al., Chemical scaffold recycling: Structure-guided conversion of an HIV integrase inhibitor into a potent influenza virus RNA-dependent RNA polymerase inhibitor designed to minimize resistance potential. Eur.J.Med.Chem. (2023)
- Release Date
- 2022-06-08
- Peptides
- Polymerase acidic protein: ABCDEFGH
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
AG
AH
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.37 Å
- Oligo State
- homo-octamer
- Ligands
- 16 x MN: MANGANESE (II) ION(Non-covalent)
- 40 x SO4: SULFATE ION(Non-functional Binders)
- 8 x QQ4: Hexa Vinylpyrrolidone K15(Non-covalent)
- 8 x 09Y: 5-hydroxy-N-[2-(2-methoxypyridin-4-yl)ethyl]-2-(2-methylphenyl)-6-oxo-1,6-dihydropyrimidine-4-carboxamide(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Slavish, P.J. et al., Chemical scaffold recycling: Structure-guided conversion of an HIV integrase inhibitor into a potent influenza virus RNA-dependent RNA polymerase inhibitor designed to minimize resistance potential. Eur.J.Med.Chem. (2023)
- Release Date
- 2022-06-08
- Peptides
- Polymerase acidic protein: ABCDEFGH
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
AG
AH
A